MedPath

Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (Phase II, multicenter, prospective, randomized, double-blinded, placebo-controlled trial)

Phase 2
Conditions
post cardiac arrest syndrome
Registration Number
JPRN-UMIN000019820
Lead Sponsor
Keio University School of Medicine, Department of Emergency and Critical Care Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
360
Inclusion Criteria

Not provided

Exclusion Criteria

1. Known pre-arrest cerebral performance category (CPC) 3 or 4. 2. Known limitations in therapy and do not resuscitate order. 3. Cardiac arrest due to trauma, strangulation, intracranial hemorrhage, subarachnoid hemorrhage, cerebral infarction, acute aortic dissection, terminal cancer, or intoxication. 4. Oxygen saturation of less than 94% with 50% oxygen inhalation and adequate positive end-expiratory pressure. 5. Pregnancy. 6. Cardiopulmonary bypass use. 7. Determined as being inappropriate for the study by site investigators .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath